Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis. [electronic resource]
Producer: 20191114Description: 1541-1548 p. digitalISSN:- 1499-2752
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Cyclophosphamide -- adverse effects
- Female
- Herpes Zoster -- epidemiology
- Humans
- Immunosuppressive Agents -- adverse effects
- Incidence
- Lupus Erythematosus, Systemic -- complications
- Male
- Middle Aged
- Retrospective Studies
- Risk Factors
- Vasculitis -- complications
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.